Tursi, Antonio https://orcid.org/0000-0001-5767-5541
Piovani, Daniele https://orcid.org/0000-0002-1414-6639
Brandimarte, Giovanni
Di Mario, Francesco https://orcid.org/0000-0002-8189-7336
Figlioli, Gisella
Dumitrascu, Dan L. https://orcid.org/0000-0001-5404-7662
Oliveira, Enio Chaves https://orcid.org/0000-0002-3502-7532
Papa, Valerio
Papagrigoriadis, Savvas https://orcid.org/0000-0002-6199-8252
Stundiene, Ieva https://orcid.org/0000-0002-2569-3638
Reichert, Matthias Christian
Regula, Jaroslaw https://orcid.org/0000-0001-7071-3151
Elisei, Walter https://orcid.org/0000-0003-4951-0194
Picchio, Marcello https://orcid.org/0000-0001-5070-8240
Bassotti, Gabrio https://orcid.org/0000-0002-0237-1812
Bafutto, Mauro https://orcid.org/0000-0001-5585-3957
Latella, Giovanni https://orcid.org/0009-0001-5797-9606
Maconi, Giovanni https://orcid.org/0000-0003-0810-4026
Bonovas, Stefanos https://orcid.org/0000-0001-6102-6579
Papa, Alfredo https://orcid.org/0000-0002-4186-7298
Danese, Silvio https://orcid.org/0000-0001-7341-1351
Funding for this research was provided by:
Università Cattolica del Sacro Cuore
Article History
Received: 16 January 2026
Accepted: 20 March 2026
First Online: 5 May 2026
Declarations
:
: Antonio Tursi served as speaker and/or consultant for AbbVie, AFI, Bayer, Celltrion, Fenix Pharma, Galápagos, Janssen, Omega Pharma and SILA; Giovanni Maconi served as a speaker and/or on advisory boards for AlfaSigma, Arena, Janssen, Gilead and Roche. Jaroslaw Regula served as a lecturer for AlfaSigma, Takeda, Ipsen and Servier; Alfredo Papa served as a speaker for AlfaSigma and Janssen. Silvio Danese served as speaker, consultant, and/or advisory board member for Abbvie, Allergan, Alfa Wassermann, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ferring, Gilead, Hospira, Johnson & Johnson, Merck, MSD, Mundipharma, Pfizer Inc., Sandoz, Takeda, Tigenix, UCB Pharma and Vifor. The remaining authors declare no competing interests.
: The study has been conducted according to the World Medical Association Declaration of Helsinki of the 1975. It was approved by the Ethics Committee of the coordinating centre and of all participating centres. The study was recorded at (NCT01534754).
: All study participants provided informed written consent prior to endoscopic investigation and to take part in this study.